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1. Introduction
Globally, as of 2010, an estimated 285 million people had diabetes, with type 2 making up
about 90% of the cases. Its incidence is increasing rapidly, and by 2030, this number is esti‐
mated to almost the double. Diabetes mellitus occurs throughout the world, but is more
common (especially type 2) in the most developed countries. The greatest increase in preva‐
lence is, however, expected to occur in Asia and Africa, where most patients will probably
be found by 2030. The increase in incidence in developing countries follows the trend of ur‐
banization and lifestyle changes, perhaps most importantly a "Western-style" diet [1].
All forms of diabetes increase the risk of long-term complications. These typically develop
after many years (10–20), but may be the first symptom among those which have otherwise
not received a diagnosis before that time. The major long-term complications relate to dam‐
age to blood vessels. Diabetes doubles the risk of cardiovascular diseases. The main "macro‐
vascular" diseases (related to atherosclerosis of larger arteries) are ischemic heart disease
(angina and myocardial infarction), stroke and peripheral vascular disease. Diabetes also
causes "microvascular" complications as damage to the small blood vessels [2]. Diabetic ret‐
inopathy, which affects blood vessel formation in the retina of the eye, can lead to visual
symptoms, reduced vision, and potentially blindness. Diabetic nephropathy, the impact of
diabetes on the kidneys, can lead to scarring changes in the kidney tissue, loss of small or
progressively larger amounts of protein in the urine, and eventually chronic kidney disease
requiring dialysis. Diabetic neuropathy is the impact of diabetes on the nervous system,
most commonly causing numbness, tingling and pain in the feet and also increasing the risk
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of skin damage due to altered sensation. Together with vascular disease in the legs, neuro‐
pathy contributes to the risk of diabetes-related foot problems (such as diabetic foot ulcers)
that can be difficult to treat and occasionally require amputation. Peripheral neuropathy is
the most prevalent complication of type 2 diabetes. The 2004 National Health and Nutrition
Examination Survey (NHANES) on lower extremity complications revealed that close to
10% of people with diabetes have peripheral arterial disease, but close to 30% have neuropa‐
thy. The survey also showed that over 7% have an active foot ulcer, a frequent cause of hos‐
pitalization and a common pathway to amputation [3].
Peripheral neuropathy is often recognized by patients or their physicians at a time when
symptoms outweigh physical signs. Sensory symptoms, paresthesias, sensory loss, and neu‐
ropathic pain are common initial complaints. Although injury to small fiber calibers and
types occurs, small-diameter unmyelinated or lightly myelinated nociceptive and autonomic
fibers are often prominently affected in these common neuropathies. There is an increasing
interest in recognizing and treating neuropathy early in its course. Sweat glands are inner‐
vated by the sudomotor, postganglionic, unmyelinated cholinergic sympathetic C-fibers that
are thin and can be damaged very early in diabetes. Sudomotor dysfunction may result in
dryness of foot skin and has been associated with foot ulceration. Assessment of sudomotor
dysfunction contributes to the detection of autonomic dysfunction in diabetic peripheral
neuropathy and American Diabetes Association suggests that sudomotor function assess‐
ment of small fiber status should be included in the diagnostic tests for the detection of neu‐
ropathies in diabetes. The quantitative sudomotor axon reflex test (QSART) is capable of
detecting distal small fiber polyneuropathy and may be considered the reference method for
the detection of sudomotor dysfunction [4]. Other available techniques for assessment of su‐
domotor function include the thermoregulatory sweat test, silastic imprint method, the indi‐
cator plaster method. But these tests are time consuming and highly specialized tests so they
are mainly used for research purposes. Skin biopsies have been developed to assess small C-
Fibers. Recently, this method has been improved by assessment of small C-Fibers that inner‐
vate sweat glands. However, this method is invasive [5].
The management of diabetes alone renders considerable expenditure, however macrovascu‐
lar and microvascular complications are the major cause of healthcare costs. Data from a
United States study indicate that renal and cardiovascular complications seem to be the
most prevalent and are associated with particularly high costs. In this study abnormal renal
function and end-stage renal disease were shown to vastly increase costs of diabetes treat‐
ment, up to 771%. Furthermore, an analysis of several individual studies showed that athe‐
rosclerosis in Type 2 diabetes accounted for approximately one third of the total healthcare
costs related to the disease. In a study of patients with myocardial infarction (MI), patients
with diabetes had a higher per-patient total direct medical charge (inclusive of initial hospi‐
talisation) compared to patients without diabetes.
In 2000, it was estimated that 25% of overweight adults aged 45-74 years had prediabetes,
which translates into about 12 million persons in the U.S. Furthermore, in the process of
identifying those with prediabetes, it was estimated that an additional 6.5 million persons
with undiagnosed diabetes would have been detected. Recent controlled trials on diabetes
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prevention have confirmed that lifestyle changes such as diet, weight loss, and exercise as
well as the drug metformin can substantially delay or prevent the progression from im‐
paired metabolism to type 2 diabetes. Thus, several million individuals could benefit from
diabetes prevention intervention [6].
There is a need to diagnose subjects with high risk for diabetes or cardiovascular diseases at
an earlier stage using a simple, non-invasive, sensitive, quick and inexpensive tool. Present‐
ly, prediabetes and diabetes are diagnosed by blood glucose or HbA1C levels with threshold
values that were initially based on risk for retinopathy, a microvascular complication. Based
on studies performed with QSART or skin biopsies, small fiber neuropathy has been shown
to develop early in patients with prediabetes or cardiometabolic risk. However, these two
highly specialized methods cannot be used for a large screening.
2. Principle of the method
EZSCAN/SUDOSCAN is  a  device  (Figure  1)  recently  developed to  provide  an  accurate
evaluation of sweat gland function [7]. Patients place their hands and feet on electrodes,
placed on skin region with a high density of  sweat  glands,  and an incremental  low di‐
rect voltage (lower than 4 V) is applied during a two minute interval. Electro-sweat con‐
ductance (ESC) is  then calculated from the resulting voltage and the generated current,
which  is  expressed in  three  ways:  (i)  current  as  a  function  of  the  anodic  potential  (so-
called E),  (ii)  current as a function of  the absolute values of  the cathodic potential  after
applying an incremental voltage at the anode (so-called V), and (iii) current as a function
of U = E+V. It is a dynamic method allowing evidence of sweat dysfunction not detecta‐
ble  in  physiological  conditions.  Quantitative  results  are  expressed  as  ESC,  in  microsie‐
mens,  µS) for  the hands and feet,  and a risk score is  derived from the ESC values and
demographic data.
3. Clinical studies for the evaluation of the performances of the device
Several studies were performed to demonstrate the robustness of the method followed by a
proof of concept study and to validate the use of the EZSCAN/SUDOSCAN in detection of
diabetes complications and in screening of prediabetes [8].
a. Symmetry
As the commonest form of diabetic neuropathy is symmetric, it was important to ensure that
ESC measurements between right and left side were comparable. In this way, ESC in hands
and feet were compared between right and left side to assess agreement between both sides
using a Bland-Altman plot [9]. Coefficient of variation calculated on 1365 subjects was 3%
for hands and 2% for feet, between right and left side.
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Figure 1. Photo of the device: screen and electrodes.
b. Gender effect
No significant difference was observed in ESC measured in hands and feet between female
and male subjects involved in the studies or surveys performed [8].
c. Reproducibility
Measurements were assessed twice in the same day in patients with at least one cardio‐
vascular  risk  and  in  patients  with  diabetes.  Results  were  compared  using  a  Bland-Alt‐
man  plot  [9].  The  coefficient  of  variation  was  7%  in  hands  and  5%  in  feet  in  patients
with cardiovascular risk and 15% in hands and 7% in feet in patients with diabetes. Co‐
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efficient  of  variation  for  glycemia,  which  is  a  gold  standard  for  diabetes,  between  the
two measurements was 32%.
d. Effects of glycemia
This technology has to be used in patients with prediabetes or diabetes, with potential high
variations in glycemia. Thus, it was important to ensure that measurements were not influ‐
enced directly by glycemia itself. Thus, measurements were performed with a set of ten pa‐
tients when their glycemia was greater than 18 mM/L and compared with measurements
performed in the same patients when glycemia was below 6 mM/L. Coefficient of variation
from a Bland and Altman plot with or without hyperglycemia was 10% for foot ESC.
e. Diagnosis of diabetes complications
• Screening of peripheral neuropathy
Perturbation of pain sensation is considered as one of the major initiating risk factors for di‐
abetic foot ulcer. Sweat dysfunction leading to abnormal skin conditions including dryness
and fissures could increase the risk of foot ulcers. The aim of this study was to evaluate SU‐
DOSCAN as co-indicator of severity of diabetic polyneuropathy. 142 patients with diabetes
(age 62 ± 18 years, diabetes duration 13 ± 14 years, HbA1c 8.9 ± 2.5%) were measured for vi‐
bration perception threshold (VPT) using a biothesiometer and for sudomotor dysfunction
by measuring ESC. Feet ESC showed a descending trend from 66 ± 17 µS to 43 ± 39 µS corre‐
sponding to an ascending trend of VPT threshold from < 15 V to > 25 V (p = 0.001). Correla‐
tion between VPT and ESC was -0.45 (p < 0.0001). Foot ESC was lower in patients with
fissures while VPT was comparable. Both VPT and foot ESC were correlated with retinop‐
athy status [10].
• Screening of cardiovascular autonomic neuropathy
Cardiovascular Autonomic Neuropathy (CAN) is a common but overlooked complication of
diabetes. SUDOSCAN was compared to Heart Rate Variability (HRV) and to Ewing tests,
known to be reliable methods for the investigation of CAN.
232 patients with diabetes were measured for HRV at rest and during moderate activity
(stair climbing). Time and frequency domain analysis techniques, including measurement of
Standard Deviation of the average beat to beat intervals (SDNN) over 5 minutes, High Fre‐
quency domain component (HF) and Low Frequency domain component (LF), were as‐
sessed during HRV testing. Heart rate variations during deep breathing and heart rate and
blood pressure responses while standing, as described by Ewing according to the recom‐
mendations of the French Health Authority were also assessed. ESC was measured on the
hands and feet, and a risk score was calculated. Patients were classified according to their
risk score. The classifications were as follow: no sweat dysfunction, moderate sweat dys‐
function and high sweat dysfunction. All results are means ± SD.
The highest correlation was observed between the risk score based on sudomotor function
and the LF component during moderate activity (r = 0.47, p < 0.001). The risk score was high‐
er in patients with a LF component value during moderate activity of < 90 ms2 (1st quartile)
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when compared to LF > 405 ms2 (3rd quartile) (46 ± 13 vs. 30 ± 13, p < 0.001). The risk score
based on sweat function was higher in patients with 2 abnormal Ewing tests when com‐
pared to patients with all tests normal (47 ± 12 vs. 34 ± 14, p < 0.001). When taking two ab‐
normal Ewing tests as reference the AUC (air under curve) of the Receiver Operating
Characteristic (ROC) curve for this risk score was 0.74 with a sensitivity of 92% and a specif‐
icity of 49% for a risk score cut-off value of 35%. Regarding ROC curve analysis when choos‐
ing LF power component during moderate activity at a threshold of 90 ms2 (1st quartile) as
reference, the AUC was higher for SUDOSCAN risk score (0.77) compared to standards Ew‐
ing tests : E/I ratio (0.62), 30:15 ratio (0.76) and blood pressure change to standing (0.65). Us‐
ing a cut-off of 35%, for SUDOSCAN risk score sensitivity and specificity were respectively
88% and 54% [11].
• Screening of diabetic nephropathy
Given the inter-relationships between dysglycemia, vasculopathy and neuropathy, it was
hypothesized that SUDOSCAN may detect diabetic kidney disease (DKD).
In a case-control cohort consisting of 50 Chinese type 2 diabetic patients without DKD (ACR
< 2.5mg/mM in men or ACR < 3.5mg/mM in women and eGFR > 90 ml/min/1.73 m2) and 50
with DKD (ACR ≥ 25 mg/mM and eGFR < 60ml/min/1.73 m2), we used spline analysis to de‐
termine the threshold value of SUDOSCAN score to predict DKD and its sensitivity and
specificity.
SUDOSCAN scores were highly correlated with log values of eGFR (r = 0.67, p < 0.0001, see
Figure 2) and ACR (r = −0.66, p < 0.0001). Using a cutoff value of 55 on the risk score scale,
the score had 94% sensitivity and 78% specificity to predict DKD with a likelihood ratio of
4.2, positive predictive value of 81% and negative predictive value of 93%. In patients with‐
out DKD, those with low SUDOSCAN score (n = 10) had longer disease duration [median
(IQR): 13 (9-17) vs. 8 (4-16) years, p=0.017] and were more likely to have retinopathy (36.7%
vs. 5.1%, p=0.02), lower eGFR [98 (95.00-103) vs. 106 (98.5-115), p = 0.036] and more treated
with RAS blockers (81.8% vs. 25.6%, p = 0.002) than those with normal score. On multivaria‐
ble analysis, SUDOSCAN score remained an independent predictor for DKD (1= yes, no = 0)
(β = −0.72, p = 0.02) along with smoking (β = −2.37, p = 0.02), retinopathy (β = 3.019, p = 0.01),
triglyceride (β = 2.56, p = 0.013) and blood hemoglobin (β = −0.613, p = 0.04) [12].
f. Proof of concept study
As sweat chloride movements in sweat ducts are likely to be impaired in cystic fibrosis (CF),
SUDOSCAN results were compared in CF patients and control subjects. ESC, measured
when a very low voltage is applied, and dESC, difference between ESC at very low voltage
and ESC at low voltage, were assessed in 41 adult patients with classical CF and 20 healthy
control subjects.
ESC measurements on hands and feet were significantly higher in CF patients as compared
to control subjects. dESC was significantly lower in CF patients and more discriminative (9 ±
18 µS vs. 49 ± 31 µS, p < 0.0001 on hands and 34 ± 24 µS vs. 93 ± 24 µS, p < 0.0001 on feet) (see
Figure 3 for an individual comparison). dESC measurement provided a diagnostic specifici‐
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ty of 1 and a sensitivity of 0.93. Correlation between feet ESC and sweat chloride concentra‐
tion as measured by sweat test was -0.70 (p < 0.0001). Precision for the measurements was
6% for hands ESC, 4% for feet ESC, 9% for hands dESC and 3% for feet dESC [13].
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Figure 2. A scatter plot and grid analysis showing the correlations between estimated glomerular filtration rate
(eGFR) and EZSCAN scores [adapted from 12].
Figure 3. Individual current-voltage current curves for a control subject and a patient with cystic fibrosis showing
dESC, the difference between ESC at low voltage and at high voltage dESC is shown by the up down arrow.
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g. Identification of subjects at high risk of diabetes
A longitudinal study was performed in subjects with an initial normal glucose tolerance
(NGT) to assess the ability of EZSCAN to predict future abnormalities in glucose tolerance.
South Asian (Indian) subjects (n = 69, 48% male, mean age 42 ± 9 years, mean BMI 28 ± 5
kg/m2) diagnosed as NGT with a previous oral glucose tolerance test (OGTT, T0) underwent
a frequently sampled OGTT (FSOGTT), 8 months later (T8) with calculation of the area un‐
der the curve (AUC) for glucose and insulin. At both times EZSCAN tests were done. Using
AUCglucose and AUCinsulin measured by the FSOGTT, subjects were categorised as normal,
high AUCinsulin or isolated high AUCglucose. Odds ratio (OR) for having high AUCinsulin or iso‐
lated high AUCglucose vs. normal was computed by logistic regression analysis using EZS‐
CAN risk classification at T0 as independent variable (< 50% = normal, no risk, 50-65% =
intermediate risk and > 65% = high risk).
At T8, 11 and 5 subjects developed impaired glucose tolerance and diabetes respectively.
OR of having high AUCinsulin  or isolated high AUCglucose  in the different risk groups was
6.19 (CI 95% 1.50– 25.48, p = 0.0116) for high risk vs. no risk and 3.0 (CI 95% 0.98–9.19, p
= 0.0545)  for  intermediate risk vs.  no risk.  Sensitivity of  EZSCAN for early detection of
these  abnormalities  in  glucose  tolerance  was  77%  while  it  was  14%  for  fasting  plasma
glucose and 66% for HbA1C [14].
h. Conclusion on clinical studies
All these clinical studies that have been published in international peer reviewed journals
evidenced that sweating status as assessed by EZSCAN/SUDOSCAN:
• is a robustness method with good reproducibility
• is a sensitive method when compared with the conventional methods may be very useful
to identify and manage subjects at risk for developing glucose intolerance
• may be a quantitative indicator on the severity of polyneuropathy that may be useful for
the early prevention of foot skin lesions
• may be used for the early screening of cardiovascular autonomic neuropathy in daily clin‐
ical practice before more sophisticated, specific, and time-consuming tests
• may be used to detect high risk subjects for diabetic kidney diseases
This quick and simple method is well accepted by the subject, does not require specific prep‐
aration and does not need high training allowing its performance by non specialized teams.
4. In-vitro study
Experiments were performed in-vitro to improve the method and to understand: i) the role
of the components of the sweat in electrochemical reaction with nickel; ii) the onsets of cur‐
rents observed in clinical studies and the influencing factors; iii) the electrochemical kinetics
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of reactions; iv) the effect of ageing of electrodes; v) the consequences on electrochemical re‐
action of the use of stainless-steel electrodes generally recommended for medical use.
4.1. Electrochemical characterization of nickel electrodes in phosphate and carbonate
electrolytes
Although the electrochemical properties of nickel have been widely examined, through the
analysis of its corrosion in aqueous acid or alkaline solution, very few studies have been
dedicated to the specific assessment of its behavior in physiological solutions. In a prelimi‐
nary study, we thoroughly explored the electrochemical behavior of nickel electrode (i) in a
three-electrode set-up combining a nickel counter electrode and a nickel pseudo-reference
electrode in order to mimic the whole Ni electrode configuration of the SUDOSCANTM de‐
vice; (ii) and in synthetic buffered phosphate and carbonate solutions (PBS and CBS) in
which the pH and the concentrations of chloride, lactate and urea were varied to mimic the
behavior of the electrodes in contact with sweat.
This approach provides insight into the origin of the onset of responses measured upon the
application of low voltage potential with variable amplitudes to Ni electrodes. This study
also constitutes a sound approach aimed at understanding the chemical key parameters con‐
trolling the electrochemical currents.
• Anodically: for low voltage amplitude, the electrochemical reactions measured at the
electrodes are mainly those related to the oxidation of Ni leading to the formation of an
oxy-hydroxide film [15]. The following reactions have been proposed for Ni oxidation in
presence of Cl- [16,17]:
Ni + H2O = Ni(H2O)ad = Ni(OH)ad + Haq+ + e−
Ni(H2O)ad + Cl- = Ni(ClOH)-ad + H+ + e-
Ni(OH)ad + H+ = Ni2+aq + (H2O)ad + e- = Ni(OH)2
At high potentials, the breakdown of the oxy-hydroxide film becomes the main anodic reac‐
tion [15]. This is mainly due to the competitive adsorption between Cl-, oxygen containing
species, carbonate anions and the formation of soluble species as Ni-Cl- and/or NiO(H)-Cl-
leading to the breakdown of the oxy-hydroxide film. This could also be due to the direct
penetration of chloride ions through the oxy-hydroxide film. Therefore, the increase in the
concentration ratios [Cl-]/[OH-] acts in favor of the adsorption of Cl- and, thus, the weakness
of the passive layer occurs, leading to its breakdown at low potential values.
• Cathodically: for low voltage amplitude, the electrochemical reactions are mainly related
to the reduction of the oxy-hydroxide film. The following reactions have been proposed:
NiO + 2H+ + 2e- → Ni + H2O
And/or
Ni(OH)2 + 2H+ + 2e- → Ni + 2H2O
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At high voltage potential, the reduction of the oxy-hydroxide film and the electrolytic solu‐
tion govern the cathode reactions [15].
In the particular case of CBS (36 mM, pH 6.4) containing different concentrations of chloride
ions, within the expected range of Cl- concentration in sweat, the positive potential going di‐
rection of the cyclic voltammograms (Figure 4) show that in all cases, an anodic plateau ap‐
pears at ca. 0.3 V, indicating the formation of a passive film composed probably by Ni(OH)2
and/or NiO.
In this examined range of potentials, the voltammograms show also a large anodic current
at high potentials due to the localized dissolution of the nickel following Cl- attack. The in‐
crease in the concentration of Cl- initiates earlier the localized dissolution of Ni. Indeed, the
breakdown potential “Eb” shifts towards lower anodic potentials when increasing the con‐
centration of Cl-.
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Figure 4. Cyclic voltammograms of Ni electrode in aerated CBS (36 mM; pH 6.4) in presence of different concentration
of NaCl. Scan rate: 100 mV/s [adapted from 15].
Moreover, the variation of buffer, urea and lactate concentrations does not have a significant
effect on the electrochemical anodic behavior of Ni and notably on the breakdown potential
“Eb”. Therefore, the anodic currents are likely to be controlled by the variation of Cl- concen‐
tration [15,18].
The obtained results (data not show) indicate that the cathodic currents are less affected by
the variation of the electrolyte concentrations and they are likely to be controlled by the var‐
iation of pH value.
4.2. Comparison of in-vitro results and clinical observations
In order to establish a parallel between the in-vitro observations and those obtained during
the clinical tests to further understand the origin of the onsets of currents and their evolu‐
tion with chloride ion concentrations, linear anodic voltammograms were performed. The
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induced potentials on the counter electrode (playing the role of cathode in this case) were
measured simultaneously. The results are then expressed, as in the medical technology (Fig‐
ure 5), as follows: (1) I vs. E, (2) I vs. V and (3) I vs. U (= E+V) where I is the current.
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Figure 5. Example of the electrochemical results obtained by the SUDOSCAN technology (1: I vs. E; 2: I vs. V; and 3: I vs.
U = E+V).
As shown above, the variation of chloride concentration is the main sweat parameter affect‐
ing the anodic electrochemical behavior of Ni. This led us to study the influence of the con‐
centrations of Cl- on the measured variation of current-voltage outputs. Linear anodic
voltammograms were performed in (I) -0.3 V to 0.9 V vs. SCE potential range and the in‐
duced potentials on the counter electrode (playing the role of cathode in this case) were
measured simultaneously. The results are then expressed, as in SUDOSCANTM technology.
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Figure 6. a) (I) j vs. E, (II) j vs. V, and (III) j vs. U (= E+V), where j is the current density, after sweeping the potential
between -0.3 V → 0.8 V vs. SCE in CBS (36 mM, pH 7) and in presence of NaCl (curves 1: 30 mM, curves 2: 60 mM,
curves 3: 90 mM, and curves 4: 120 mM). (b) Evolution of Eb, Vb and Ub as a function of Log[Cl-] (data from Figure 6a)
[adapted from 19].
In the particular case of pH 7, Figure 6a depicts the results obtained in CBS (36 mM, pH 7),
containing different concentrations of NaCl (30, 60, 90, and 120 mM). It clearly appears that
the concentration of Cl- affects the variation of the current as a function of E, V and U. In
fact, the increase in the concentration of Cl- shifts linearly the breakdown potential, Eb, to‐
wards more cathodic values, as it can be seen in Figure 6b. According to the same way than
Eb, Vb and Ub can be also evaluated as the potentials associated to the point of deviation of j-
V and j-U curves. Figure 6b shows that the increase in the concentration of Cl- shifts linearly
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Eb and Vb towards lower V values and the slope value of Vb vs. Log[Cl-] is close to that of Eb
vs. Log[Cl-]. Consequently, the increase in Cl- concentration shifts linearly Ub towards lower
U values and the slope of Ub vs. Log[Cl-] is about twice the value found for Eb or Vb vs.
Log[Cl-]. It should be noted that the results obtained at pH 6 provided the same features as
in the present case. This implies that the evolution of the current-voltage curves reported in
Figures 6a and 6b are not very sensitive to the variation of pH values.
Furthermore, curves obtained for generated current as a function of E, V, U during clinical
tests are quite comparable (Figure 5 and 6a). These results led us to conclude that the deter‐
mination of the current curve as a function of the potential (anode, cathode or their differ‐
ence) provides a very efficient way to detect the deviation in the ion balance and notably the
deviation in Cl- concentration at the level of the electrodes.
4.3. Electrochemical kinetics of anodic nickel dissolution
As shown above, the variation of chloride ion concentration plays a key role in predict‐
ing  sudomotor  dysfunction  by  controlling  the  generated  current  at  high  anodic  poten‐
tials,  notably  the  currents  related to  the  localized anodic  dissolution of  nickel.  This  led
us to study the kinetics of the different electrochemical reactions related to the localized
dissolution  of  nickel  in  carbonate  buffer  solutions  (CBS)  at  different  physiological  pH
values  and in  presence of  different  concentrations  of  chloride ions,  within the  expected
range  of  concentrations  in  sweat  at  rest.  This  aims  at  studying  the  mechanisms  of  the
electrochemical reactions and completing a theoretical model on the basis of the electrical
signals registered during the clinical tests. Our results show that in a pH range between
5-7,  the  rate  determining step appears  to  be  the  transfer  of  a  first  one-electron,  as  sug‐
gested by Tafel  slopes close to  0.120 V/decade.  However,  the reaction order  in  chloride
ions changes from around 2, for pH 7, to around 1, for pH values between 6 and 5 with‐
out a change in the rate-determining step [20].
At pH 7, the following mechanism has been proposed for the reactions taking place before
and during the rate determining step (rds):
1. Ni + 2Cl- ⇆ [NiCl2]2-ads
2. [NiCl2]2-ads ⇆ [NiCl2]- + e- rds
And at pH 5-6, the following mechanism has been proposed:
1. Ni + Cl- (aq) ⇆ Ni(Cl-)ads
2. Ni(Cl-)ads⇆ Ni(I)Cl + e- rds
4.4. Effect of electrode ageing on measurements
The nickel electrodes play alternately the role of anode and cathode, which do not undergo
any specific pretreatment before each measurement. Thus, the analysis of the temporal evo‐
lution of the physico-chemical properties of nickel is of prime importance to ensure the good
performance of the medical device. The objectives of the present work are to study both the
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electrochemical behavior and the surface chemical composition of nickel electrodes after
ageing under repeated cyclic voltammograms in different potential windows. Surface chem‐
ical characterizations by XPS (X-ray photoelectron spectroscopy) and ToF-SIMS (Time of
Flight-Secondary Ion Mass Spectrometry) were performed on nickel electrodes after ageing
with repeated cyclic voltammograms in carbonate buffer solutions containing the main com‐
ponents of sweat, at different potential ranges, in: (i) a restricted anodic potential range; (ii) a
negative extended potential range.
The electrochemical behavior of Ni electrodes was first studied after ageing with repeated
cyclic voltammograms in a potential range of -0.3 V to 0.5 V and return to -0.3 V (anodic
region only). Then, in order to assess the influence of alternating the polarity of the electro‐
des during the clinical tests on the Ni ageing behavior (each electrode playing alternately the
role of anode or cathode), successive cyclic voltammograms were performed in a potential
range of -0.3 V → 0.5 V → -1 V (cathodic region). All the experiments were conducted in aer‐
ated CBS solutions, with a concentration of 120 mM of NaCl.
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Figure 7. Successive cyclic voltammograms of Ni electrode in CBS (pH 6.4) in presence of 120 mM NaCl. Scan rate: 100
mV/s. (a) potential range: -0.3 V → 0.5 V → -0.3 V and (b) potential range: -0.3 V → 0.5 V → -1.0 V [adapted from 21].
Figure 7a shows cyclic voltammograms after 1, 4 and 8 cycles in aerated CBS (36 mM) in
presence of Cl- (120 mM) in the potential range [-0.3 V → 0.5 V → -0.3 V]. It clearly appears
that the first potential sweep strongly affects the subsequent cyclic voltammograms. The
anodic plateau of the first cycle, attributed to Ni oxidation, is no longer observed in the fol‐
lowing cycles (see, for example, the voltammograms of the fourth cycle and eighth cycles in
Figure 7a). These changes in the voltammograms are mainly attributed to the formation of
an oxide layer firmly attached to the metal and forming a compact barrier between the metal
and the solution with a very low electronic conductivity during the first cycle [22].
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Figure 7b shows the obtained cyclic voltammograms after 1, 6 and 12 cycles when the poten‐
tial on the return cycle is extended to -1 V (potential range [-0.3 V → 0.5 V → -1 V → -0.3 V]).
Contrarily to the results presented in Figure 7a, there are two new observations: (i) the Ni
oxidation process is still observed during the subsequent cycles around -0.4 V and 0.4 V, (ii)
the high intensities of the anodic current remain with the subsequent cycles. This is mainly
due to a partial reduction or re-activation [22,23] of the compact oxide film when the poten‐
tial scan is extended down to -1 V. The re-activation of the oxide film, in the cathodic reduc‐
tion step, is probably due to a surface modification or post-electrochemical re-organization
of the initial deposited species [24] leading to an increase in the electronic conductivity of
the surface of the Ni electrode.
It should be noted here that additional experiments, performed in the absence of Cl-, dis‐
played the same features as in the present case (data not shown). This implies that the vol‐
tammograms reported in Figure 7 are poorly sensitive towards the presence of Cl-, as the
potential range is well below the pitting corrosion one.
XPS  characterizations  were  performed on  the  series  of  samples  shown in  Figures  7a-b.
The Ni 2p3/2  core levels were systematically decomposed into the spectroscopic contribu‐
tions characteristic of metallic nickel (main peak located at a BE of 852.8 ± 0.2 eV, nickel
plasmon at 856.3 ± 0.2 eV and satellite at 858.8 ± 0.2 eV [25-27]), nickel oxide NiO (main
peak located at 854.7 ± 0.2 eV and two satellites located at 856.4 ± 0.2 eV and 861.7 ± 0.2
eV  [25-27])  and  Ni(OH)2  (main  peak  at  856.7  ±  0.2  eV  and  satellite  at  862.6  ±  0.2  eV
[26,27]).  Figure 8 displays these core levels and their decomposition into individual con‐
tributions of Ni, NiO, and Ni(OH)2.
Based on previously published data, a simple layer model of the passive film can be sug‐
gested. It is composed of an homogeneous continuous outermost layer of Ni(OH)2 and an
homogeneous continuous inner NiO oxide layer, in contact with the metal [28,29].
It was possible to calculate the equivalent thicknesses of the Ni(OH)2 and NiO layers, as well
as the total oxidized surface layer (as the arithmetic sum of the two former ones), from the
peak intensities of the fitted Ni 2p3/2 core levels, taking into account such two-layer model
for the description of the Ni oxide film (see Equations 1 and 2) in all experiments. The values
are reported in Table 1.
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Where d  is the layer thickness, β is the take-off angle of the photoelectrons with respect
to  the  sample  surface,  λMN is  the  inelastic  mean  free  path  of  the  photoelectrons  coming
Electrochemical Basis for EZSCAN/SUDOSCAN: A Quick, Simple, and Non-Invasive Method to Evaluate Sudomotor
Dysfunctions
http://dx.doi.org/10.5772/53965
69
from M in the matrix N, INiNiis  the nickel  intensity for NiO in the bulk metal,  INiNi(OH )2is
the  nickel  intensity  for  Ni(OH)2,DMN  is  the  density  of  M  in  the  matrix  N,  the  inelastic
mean free paths used in this  work are the following:  1.41 nm for λNiNi  [26],  1.43 nm for
λNiNiO  [26] and 1.19 nm for λNiNi(OH )2 [26].
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Figure 8. XPS Ni 2p3/2 core level peak decompositions of a Ni electrode immersed in carbonate buffer saline solution
(pH 6.4), in presence of 120 mM NaCl, for different numbers of cycles in different potential range [adapted from 21].
In a restricted anodic potential range, XPS results indicate that the surface was passivated by
a 1 nm-thick duplex layer composed of nickel hydroxide (outermost layers) and nickel oxide
(inner layers). In a negative extended potential range, though the electrochemical behavior
of electrodes did not change, the inner nickel oxide layer was thickening, indicating a sur‐
face degradation of the nickel electrode in these conditions.
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Sample treatment NiO equivalent thickness(nm)
Ni(OH)2 equivalent
thickness (nm) Passive layer thickness (nm)
-0.3 V→ 0.5 V→ -0.3V with 120 mM NaCl
1 cycle 0.7 ± 0.1 0.5 ± 0.1 1.2 ± 0.2
4 cycles 0.7 ± 0.1 0.7 ± 0.1 1.4 ± 0.2
8 cycles 0.9 ± 0.1 0.7 ± 0.1 1.6 ± 0.2
-0.3V→ 0.5 V→ -1.0 V with 120 mM NaCl
1 cycle 0.5 ± 0.1 0.8 ± 0.1 1.3 ± 0.2
6 cycles 1.4 ± 0.1 1.3 ± 0.1 2.7 ± 0.2
12 cycles 2.6 ± 0.1 1.4 ± 0.1 4.0 ± 0.2
-0.3V→ 0.5 V→ -1.0 V without 120 mM NaCl
1 cycle 0.7 ± 0.1 1.0 ± 0.1 1.7 ± 0.2
6 cycles 1.8 ± 0.1 1.1 ± 0.1 2.9 ± 0.2
12 cycles 2.3 ± 0.1 1.8 ± 0.1 4.1 ± 0.2
Table 1. NiO and Ni(OH)2 layer thicknesses estimated from the XPS Ni 2p3/2 core level peak decompositions (two-layer
model) [adapted from 21].
These systematic observations, in different potential ranges, show that alternating the polar‐
ity of the electrodes ensures the reproducibility of measurements for a large number of clini‐
cal tests and explain why, during routine use of the medical device, the metal/sweat
interaction may reduce the lifetime of the anodic and/or cathodic electrodes.
4.5. Stainless-steel electrodes behavior: Comparison with nickel
Although the contact duration of nickel with skin is only about 2 minutes, the risk of allergic
reactions cannot be discarded. In order to improve the device, a new electrode material,
stainless steel 304L (SS 304L), with lower Ni content, was tested in carbonate buffer solu‐
tions in the presence of various concentrations of chloride, lactate and urea to mimic the
chemical composition of the sweat.
Stainless steel 304L (SS 304L), already used in surgical instruments for example, was select‐
ed as a potential substitute material. Thus, the electrochemical behavior of SS 304L was ana‐
lyzed and, more particularly, its sensitivity to the variation of different parameters in sweat.
This work is aimed at understanding the adequacy of stainless steel 304L to the clinical test‐
ing application. The electrochemical measurements were performed in a three-electrode set
up combining a stainless steel 304 L counter electrode in order to mimic the 2 active electro‐
des configuration (the same material is used for the anode and the cathode) of the SUDO‐
SCANTM device.
As for nickel, the influence of the variation of electrolyte concentrations on the electrochemi‐
cal behavior of SS 304L, mainly appears by a deviation of the generated currents at high
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anodic voltage potential and notably the deviation of the breakdown potential, Eb, towards
less or higher anodic potentials.
The obtained results show that SS 304L is more sensitive than Ni to the variation of Cl- con‐
centration. Figure 9 shows the cyclic voltammograms recorded on SS 304L in carbonate buf‐
fer solutions (36 mM, pH 7) without Cl- and with increasing concentrations of Cl- within the
expected range of concentrations in sweat at rest. In all cases, the concentration of Cl- is high
enough to cause the destruction of the passive film. Furthermore, Eb decreases with increas‐
ing chloride concentration. A high shift of about 0.42 V was observed by varying chloride
concentration from 30 to 120 mM at pH 7.
As for nickel,  a linear variation between Eb  and Log([Cl-])  was also observed. However,
SS 304L is  more sensitive than Ni to the variation of  Cl-  concentration.  The slope value
of the linear variation of Eb as a function of Log([Cl-]) was ≈ 0.2 for Ni and ≈ 0.67 for SS
304L (Figure 10).
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Figure 9. Cyclic voltammograms of SS 304L electrode in aerated CBS (36 mM, pH 7) in presence of NaCl (curve 1: 0
mM; curve 2: 30 mM; curve 3: 45 mM; curve 4: 60 mM; curve 5: 75 mM; curve 6: 90 mM and curve 7: 120 mM). Only
the forward scans are shown. Scan rate: 100 mV/s [adapted from 30].
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Figure 10. Eb vs. Log [Cl-]. Data obtained from cyclic voltammograms on (1 : SS 304L electrode; 2 : nickel electrode) in
carbonate buffer solutions (36 mM, pH 7) in presence of different concentrations of Cl- (between 30 and 120 mM).
The effect of adding increasing amounts of Cl- on Eb of SS 304L in CBS (36 mM) at pH 5, 5.5
and 6 was also examined. Table 2 presents the Eb values deduced from cyclic voltammo‐
grams recorded (data not shown) at different pH and chloride ions concentration. It clearly
appears that, at pH 5 and 5.5, the localized dissolution occurs only when Cl- concentration
exceeds 40 mM, whilst at pH 6, Cl- concentration should exceed 30 mM.
[NaCl](mM) Eb, VSCE (pH 5) Eb, VSCE (pH 5.5) Eb, VSCE (pH 6) Eb, VSCE (pH 7)
0 1.38 1.38 1.34 1.30
30 1.38 1.38 1.31 1.06
40 1.38 1.38 1.15 0.90
60 1.07 1.03 0.92 0.805
90 0.88 0.83 0.79 0.70
120 0.77 0.76 0.73 0.64
Table 2. Eb values deduced from cyclic voltammograms recorded on SS 304L in CBS of different pH and containing
various chloride ions concentration [30].
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The effect  of  pH, buffer  concentration,  urea concentration and lactate concentration was
also  studied.  The  obtained  results  show that  variation  of  pH,  buffer  concentration  and
lactate concentration also affect, but to a less extent than chloride, the electrochemical be‐
havior  of  SS  304L  by  displacing  Eb  towards  lower  or  higher  anodic  potentials  [30].  As
the variation range of these parameters in sweat is  low compared to that of Cl-,  and as
the breakdown potential  (Eb)  is  highly shifted by varying Cl-  concentration, the currents
obtained during the clinical  tests  are likely to be controlled by the variation of  Cl-  con‐
centration.  These  results  tend  to  prove  that  SS  304L  is  suitable  for  use  in  the  SUDO‐
SCANTM  application due to its high capacity to detect the deviation in the ionic balance
and notably the deviation in Cl- concentration.
5. Conclusion
The study of the electrochemical behavior of nickel was carried out in sweat-mimic solu‐
tions and using a set-up similar to that of the medical device. This study allowed us to de‐
fine the origin of the onset of responses measured upon the application of low voltage
potential with variable amplitudes to Ni electrodes. This study also clearly indicates that the
variation of chloride concentration is the main sweat parameter controlling the electrochem‐
ical currents.
The comparisons between in-vitro study and clinical observations clearly indicate that the
electrochemical in-vitro measurements on the behavior of nickel electrodes are close enough
to those obtained through the clinical tests and prove that the determination of the current
curve as a function of the potential (anode, cathode or their difference) provides a very effi‐
cient way to detect the deviation in Cl- concentration, at the level of the electrodes.
The influence of chloride concentrations on the kinetics of the electrochemical reactions was
also studied. The proposed mechanisms and the obtained kinetic parameters were then used
by Impeto Medical to complete a theoretical model.
An evaluation of the ageing of electrodes on their performance was conducted by realizing
surface analyzes, such as XPS and SIMS spectroscopies. Our results have highlighted the im‐
portance of alternating the polarity of electrodes to ensure their sensitivity and the reprodu‐
cibility of measurements. However, after frequent uses, the metal/sweat interaction can lead
to a slight deterioration of the electrodes surface.
Finally, in order to reduce the allergic risk, the electrochemical studies were extended to the
stainless steel 304L as a replacement material of nickel. The electrochemical study shows
that stainless steel 304L is very sensitive to the deviation of sweat ionic balance and notably
to the variation of chloride concentrations at the level of electrodes. This makes stainless
steel 304L a very promising material for the medical device application.
Results obtained from in-vitro studies have been used to improve the development of EZS‐
CAN/SUDOSCAN.
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In perspective, it could be interesting to compare the electrochemical behavior and surface
modification between electrodes aged in-vivo and electrodes aged in-vitro and to study the
electrochemical behavior of different compositions of stainless steel. It could be also interest‐
ing to study the electrochemical kinetics of anodic reactions taking place at the surface of
stainless steel electrode in physiological solutions.
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